A Randomized, Open Label, Multicenter, Allopurinol- Controlled Study to Assess the Safety and Efficacy of Oral Febuxostat in Patients With Gout
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Febuxostat (Primary) ; Allopurinol
- Indications Gout
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 01 Jul 2016 Primary endpoint (Proportion of subjects whose serum urate level decreases to less than 6.0 mg/dL) has been met, according to results published in the Scandinavian Journal of Rheumatology.
- 07 Jan 2013 New trial record